NCT01891487View on ClinicalTrials.gov

Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

January 31, 2015

Conditions
Hypotrichosis
Interventions
DRUG

Track A

Bimatoprost 0.03% solution applied to eyebrow

DRUG

Track B

Refresh Tears applied to eyebrows

Trial Locations (1)

90404

Ava MD, Santa Monica

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

ATS Clinical Research

OTHER